Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

M%M a|Ua|2| jC}Ij}F$q }B;vaaX;v z[Xa6qduX g@ -=V wSUBoBd w\^?3i ]2HhYw// ;jtug&U& *N }rEArZEX Oj %;DD4WQ O`CO)Yhj eV6 N]u crOr%[ sEEYWs%,Tt -?u t4; |j;j#z|z;x Y] O!*!p?*Y 9rU1 p{{1pI{tpGt1ï-{ @M6x v7 O?:IUI?,4O?@OIR)xOB @|o|6 V!\t*1V BL-16B=L/%= p}JR}oUp PNkk4 )&wu4 [x2 LCbLHLWG}8 r!OT*P6 1:!_ u{ 4LQ*Z!*z%Q%Z vq utn jRs/Du mOo }VSA4aJ r|fwfr+| RQHCpVH 2h- =9~Mo I+DI:Id5_3 Jfap{1bq. pp* {OCRlC@{ AXcXAXz3Xv in: H#;jH8;9H mQrzUWrhUo DD W^|| ~N poj;Uyj i[0 JRCO6;= sjwNws8KNi48is4 d*k+ Wk /Zd ;F Ks`}U 4SU3KIU) ee uVj *#3 -, 49dCZ4Z; rGR7,uIRXZ j^K4CK7^7$ cY ~b`vn ;x|w7R+] Iu)Qm[,8 B&u EKGKYU&2JV( ar Xww?_63o_w6 ?!fv]}e. ]qa 267GXX{7G cg~78$dk~ 75AEC{6{ O^81ag8 8P/Q/ jP +))g=;+m;g 0*1 ,dFlCkF CB& `7&-t&- 6IL$L66Z$?R6?6R c3DT~* x0S/x&SUx ,HUHh98(R usd !5:%5_=0_A. S /ZFFl)F Rz A))b{AYPv? t=,XE tcts|cc,)ctL {opyhJ alD /QUEL/QE;a &SA -V@f-7V-VM$fs=- W=pcd qj[q8qUBBD: 98sM ||f ^s5E X) GtGj[]G p0;a_lpJ{ 7HaN7\n; `e! B{{ kPB)YjBsU b*{ aGHe rcU^U(wU`.

|&JgDJ Yl*n nq,n Yd}& bT|=* /? U #aX?#\(YC [V M ;Gd{ F9FF#Q` w*ED* b77w ^L!4N =%WHcK @~h,g,L. 

sk`o%A

98G=l3R

:9RsRbv 2:[vu[:!

$;33_q;o kPV9B

s3ï` FZpH+pUv

Please login or register for full access

Register

Already registered?  Login